Imaging the Pathogenesis of Cerebral Small Vessel Disease

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Johns Hopkins University
Study ID
NCT05703386
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Cerebral small vessel disease (CSVD) can lead to vascular cognitive impairment and dementia (VCID). The hallmark of CSVD is the appearance and progression of white matter hyperintensities (WMH) on MRI. The goal of this study it to recruit and follow individuals at risk for WMH progression and use serial MRI scanning to gain insights into the pathogenesis of CSVD.

Key Dates

Start date
Nov 8, 2022
Status verified
Mar 2026
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
50 participants (estimated)

Primary Outcome Measure

Progression of cerebral small vessel disease [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Kennedy Krieger InstituteBaltimoreMaryland21205
Pooja Patel
[email protected]
410-502-5355

Find similar trials in Baltimore, MD

By condition
Hypertension (high blood pressure)Stroke
By specialty
CardiologyHeart diseaseNeurologyBrain disorders
By research site
Kennedy Krieger Institute· Baltimore, MD

Related Studies